Member Info for Tra1

moving up now, 10 paid

expect people bring their profits from rms, brh...etc. here soon

patience, 11.40 being just paid, journey only starting, still standing by my estimate of .25+ before the trial report

thanks prosper, 0.065

filling in the space:

BRH from 12 to 60 since 17July,
RMS from 0.45 to 4.5 from since 23 Sept, Because of a face mask that can kill the virus!
Vela from 0.65 (since the first acquisition) to ..... ......Dec 20 (phase II trial)

bullish pattern, let us see how this falling wedge plays out_ https://invst.ly/so9sa

almost all the charts in my watch list look similar inc. Crude, sp500, F100, =maximum dip in Thurs, higher low on Frid showing recovery in the afternoon session, so do not expect any lower, it is a bargain price now before the next leg up

This first commercial production and sale marks another step in the development plan of the small-scale operation whilst plans for the development of Balasausqandiq continue and will bring a significant increase in revenue, complementing recent record levels of production.

.....the company has the option to source raw materials with molybdenum as the primary metal where it is more profitable to do so, and is in discussions with potential off-takers and expects to sign a long-term contract shortly.....

this share will multibag on news of the the covid trial expected Nov/Dec time, the drug is already effective in diabetes patients, they just want to stamp it with a randomised controlled trial, from my experience -;

That drop was bought very fast! watch for a green afternoon as people bring their profits from other shares here

and when rms falls and Vela rallies you come and say "I should ve put more in vella” right?

Strong support, people selling now will have to buy at much higher price, i ve seen it happening few times here. People sold at .0.6 only to get this wonderful rns news in the afternoon and you know what happened after that, re rate in progress, story just beginning, atb

i am sure we will get news on the next investment soon as we still have cash, maybe another covid or pharma play?

https://www.diabetes.org.uk/research/take-part-in-research/arcadia-trial-treatment

https://clinicaltrials.gov/ct2/show/NCT04516759

i meant the clinical study outcome which is due to be reported by Dec.

in fact this was one of the com i was researching and thought it will rto with us

this could be sooner , by Dec. is my estimate, which would fit with the report of the study

Good morning, excellent post Pike,

Yeh no one knows the target. As you said for these tests sensitivity and specificity r very important. The rns mentioned patented; which is excellent for commercialisation. Not sure about the cqc (mainly checking on premises like clinics, hospitals, nursing hs etc..), i ld ”think” that the lse have asked for some sort of clarification/relplies/paperwork etc) hence the delay, hopefully sorted now. Validation? again, i am not sure, usually done through clinical trials, you would think this has been done already. However, not all the tests in the market have been validated before going in the stock market. Lots of speculations but fromwhat i read and hear (as in the article) that cancer screening is gaining attraction from big investors, hoping to see (over subscribed) in the re admission rns.

Today there was an IPO for Sourcebio for 168P ! they are apparently dealing with similar tests, our day will come -:)

https://www.investegate.co.uk/sourcebio-intl-plc/rns/aim-admission---first-day-of-dealings/202010290700075399D/
https://sourcebiointernational.com/business-overview/

just testing, i can not see my earlier message